No Benefit With Rituximab Maintenance Following Complete Remission for Diffuse Large B-Cell Lymphoma
Patients receiving rituximab maintenance and undergoing observation demonstrated similar rates of overall and disease-free survival.
All articles by Vicki Moore, PhD
Prognostic Factors for Outcomes of Allogeneic Hematopoietic Cell Transplantation in Geriatric Patients
Impaired ability to conduct instrumental activities of daily living and high disease risk index were associated with poorer outcomes.
Induction Chemotherapy Intensity May Not Influence Survival in Acute Myeloid Leukemia
Intensity of induction chemotherapy was associated with measurable residual disease negativity but not overall survival.
Meta-Analysis of Progression-Free Survival in Phase 3 Trials of Follicular Lymphoma Treatments
In this meta-analysis, researchers analyzed progression-free survival outcomes for 11 treatment regimens in pairwise comparisons.
Daratumumab Improves Outcomes in Combination With Lenalidomide, Dexamethasone for Relapsed/Refractory Multiple Myeloma
Patients with both high and standard cytogenetic risk who received daratumumab experienced increased PFS.
Tumor Lysis Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax
High risk for tumor lysis syndrome and creatinine clearance below 80 mL/min were associated with tumor lysis syndrome development.
Autologous Stem Cell Transplantation Outcomes in Patients With Peripheral T-Cell Lymphomas
Patients with higher International Prognostic Index scores or advanced-stage disease experienced improved survival when treated with ASCT.
Determining Response and Outcomes With Eltrombopag Treatment for Refractory Severe Aplastic Anemia
Of 20 patients who showed response to eltrombopag at 24 weeks, 25% had not shown response at 12 weeks.
Detection and Management of Factor XIII A-Subunit Deficiency in Neonates
Researchers analyzed the clinical features of factor XIII deficiency in neonates and used the data to develop a diagnostic algorithm.
Bleeding Risks for Patients With Cancer on Anticoagulant Therapy
For all anticoagulants examined, patients with cancer had higher bleeding incidence rates than patients without cancer.
Next post in Bleeding Disorders
